Global Tuberculosis Diagnostic Market Size, Status and Forecast 2020-2026

Code: QYRE-Auto-12V1854

Report

2020-03-11

Pages:98

QYResearch

Description

Table of Content

Tables & Figures

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tuberculosis Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tuberculosis Diagnostic market in terms of revenue.

Players, stakeholders, and other participants in the global Tuberculosis Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Tuberculosis Diagnostic market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Tuberculosis Diagnostic market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tuberculosis Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tuberculosis Diagnostic market.

The following players are covered in this report:

Thermo Fisher Scientific
Hologic Corporation
Abbott Laboratories
Abbott
Becton
Dickinson and Company
Hoffmann-La Roche
bioMerieux
Sanofi
Cepheid
Hain Lifescience
QIAGEN

Tuberculosis Diagnostic Breakdown Data by Type

Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance

Tuberculosis Diagnostic Breakdown Data by Application

Infants
Adults

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Tuberculosis Diagnostic Revenue

1.4 Market Analysis by Type

1.4.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Type: 2020 VS 2026

1.4.2 Radiographic Method

1.4.3 Diagnostic Laboratory Methods

1.4.4 Nucleic Acid Testing

1.4.5 Phage Assay

1.4.6 Detection of Latent Infection

1.4.7 Cytokine Detection Assay

1.4.8 Detection of Drug Resistance

1.5 Market by Application

1.5.1 Global Tuberculosis Diagnostic Market Share by Application: 2020 VS 2026

1.5.2 Infants

1.5.3 Adults

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends by Regions

2.1 Tuberculosis Diagnostic Market Perspective (2015-2026)

2.2 Tuberculosis Diagnostic Growth Trends by Regions

2.2.1 Tuberculosis Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026

2.2.2 Tuberculosis Diagnostic Historic Market Share by Regions (2015-2020)

2.2.3 Tuberculosis Diagnostic Forecasted Market Size by Regions (2021-2026)

2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

2.3.5 Tuberculosis Diagnostic Market Growth Strategy

2.3.6 Primary Interviews with Key Tuberculosis Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players

3.1 Global Top Tuberculosis Diagnostic Players by Market Size

3.1.1 Global Top Tuberculosis Diagnostic Players by Revenue (2015-2020)

3.1.2 Global Tuberculosis Diagnostic Revenue Market Share by Players (2015-2020)

3.1.3 Global Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.2 Global Tuberculosis Diagnostic Market Concentration Ratio

3.2.1 Global Tuberculosis Diagnostic Market Concentration Ratio (CR5 and HHI)

3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostic Revenue in 2019

3.3 Tuberculosis Diagnostic Key Players Head office and Area Served

3.4 Key Players Tuberculosis Diagnostic Product Solution and Service

3.5 Date of Enter into Tuberculosis Diagnostic Market

3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

4.1 Global Tuberculosis Diagnostic Historic Market Size by Type (2015-2020)

4.2 Global Tuberculosis Diagnostic Forecasted Market Size by Type (2021-2026)

5 Tuberculosis Diagnostic Breakdown Data by Application (2015-2026)

5.1 Global Tuberculosis Diagnostic Market Size by Application (2015-2020)

5.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America

6.1 North America Tuberculosis Diagnostic Market Size (2015-2020)

6.2 Tuberculosis Diagnostic Key Players in North America (2019-2020)

6.3 North America Tuberculosis Diagnostic Market Size by Type (2015-2020)

6.4 North America Tuberculosis Diagnostic Market Size by Application (2015-2020)

7 Europe

7.1 Europe Tuberculosis Diagnostic Market Size (2015-2020)

7.2 Tuberculosis Diagnostic Key Players in Europe (2019-2020)

7.3 Europe Tuberculosis Diagnostic Market Size by Type (2015-2020)

7.4 Europe Tuberculosis Diagnostic Market Size by Application (2015-2020)

8 China

8.1 China Tuberculosis Diagnostic Market Size (2015-2020)

8.2 Tuberculosis Diagnostic Key Players in China (2019-2020)

8.3 China Tuberculosis Diagnostic Market Size by Type (2015-2020)

8.4 China Tuberculosis Diagnostic Market Size by Application (2015-2020)

9 Japan

9.1 Japan Tuberculosis Diagnostic Market Size (2015-2020)

9.2 Tuberculosis Diagnostic Key Players in Japan (2019-2020)

9.3 Japan Tuberculosis Diagnostic Market Size by Type (2015-2020)

9.4 Japan Tuberculosis Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia

10.1 Southeast Asia Tuberculosis Diagnostic Market Size (2015-2020)

10.2 Tuberculosis Diagnostic Key Players in Southeast Asia (2019-2020)

10.3 Southeast Asia Tuberculosis Diagnostic Market Size by Type (2015-2020)

10.4 Southeast Asia Tuberculosis Diagnostic Market Size by Application (2015-2020)

11 India

11.1 India Tuberculosis Diagnostic Market Size (2015-2020)

11.2 Tuberculosis Diagnostic Key Players in India (2019-2020)

11.3 India Tuberculosis Diagnostic Market Size by Type (2015-2020)

11.4 India Tuberculosis Diagnostic Market Size by Application (2015-2020)

12 Central & South America

12.1 Central & South America Tuberculosis Diagnostic Market Size (2015-2020)

12.2 Tuberculosis Diagnostic Key Players in Central & South America (2019-2020)

12.3 Central & South America Tuberculosis Diagnostic Market Size by Type (2015-2020)

12.4 Central & South America Tuberculosis Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles

13.1 Thermo Fisher Scientific

13.1.1 Thermo Fisher Scientific Company Details

13.1.2 Thermo Fisher Scientific Business Overview and Its Total Revenue

13.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Introduction

13.1.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2015-2020))

13.1.5 Thermo Fisher Scientific Recent Development

13.2 Hologic Corporation

13.2.1 Hologic Corporation Company Details

13.2.2 Hologic Corporation Business Overview and Its Total Revenue

13.2.3 Hologic Corporation Tuberculosis Diagnostic Introduction

13.2.4 Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2015-2020)

13.2.5 Hologic Corporation Recent Development

13.3 Abbott Laboratories

13.3.1 Abbott Laboratories Company Details

13.3.2 Abbott Laboratories Business Overview and Its Total Revenue

13.3.3 Abbott Laboratories Tuberculosis Diagnostic Introduction

13.3.4 Abbott Laboratories Revenue in Tuberculosis Diagnostic Business (2015-2020)

13.3.5 Abbott Laboratories Recent Development

13.4 Abbott

13.4.1 Abbott Company Details

13.4.2 Abbott Business Overview and Its Total Revenue

13.4.3 Abbott Tuberculosis Diagnostic Introduction

13.4.4 Abbott Revenue in Tuberculosis Diagnostic Business (2015-2020)

13.4.5 Abbott Recent Development

13.5 Becton

13.5.1 Becton Company Details

13.5.2 Becton Business Overview and Its Total Revenue

13.5.3 Becton Tuberculosis Diagnostic Introduction

13.5.4 Becton Revenue in Tuberculosis Diagnostic Business (2015-2020)

13.5.5 Becton Recent Development

13.6 Dickinson and Company

13.6.1 Dickinson and Company Company Details

13.6.2 Dickinson and Company Business Overview and Its Total Revenue

13.6.3 Dickinson and Company Tuberculosis Diagnostic Introduction

13.6.4 Dickinson and Company Revenue in Tuberculosis Diagnostic Business (2015-2020)

13.6.5 Dickinson and Company Recent Development

13.7 F. Hoffmann-La Roche

13.7.1 F. Hoffmann-La Roche Company Details

13.7.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue

13.7.3 F. Hoffmann-La Roche Tuberculosis Diagnostic Introduction

13.7.4 F. Hoffmann-La Roche Revenue in Tuberculosis Diagnostic Business (2015-2020)

13.7.5 F. Hoffmann-La Roche Recent Development

13.8 bioMerieux

13.8.1 bioMerieux Company Details

13.8.2 bioMerieux Business Overview and Its Total Revenue

13.8.3 bioMerieux Tuberculosis Diagnostic Introduction

13.8.4 bioMerieux Revenue in Tuberculosis Diagnostic Business (2015-2020)

13.8.5 bioMerieux Recent Development

13.9 Sanofi

13.9.1 Sanofi Company Details

13.9.2 Sanofi Business Overview and Its Total Revenue

13.9.3 Sanofi Tuberculosis Diagnostic Introduction

13.9.4 Sanofi Revenue in Tuberculosis Diagnostic Business (2015-2020)

13.9.5 Sanofi Recent Development

13.10 Cepheid

13.10.1 Cepheid Company Details

13.10.2 Cepheid Business Overview and Its Total Revenue

13.10.3 Cepheid Tuberculosis Diagnostic Introduction

13.10.4 Cepheid Revenue in Tuberculosis Diagnostic Business (2015-2020)

13.10.5 Cepheid Recent Development

13.11 Hain Lifescience

10.11.1 Hain Lifescience Company Details

10.11.2 Hain Lifescience Business Overview and Its Total Revenue

10.11.3 Hain Lifescience Tuberculosis Diagnostic Introduction

10.11.4 Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2015-2020)

10.11.5 Hain Lifescience Recent Development

13.12 QIAGEN

10.12.1 QIAGEN Company Details

10.12.2 QIAGEN Business Overview and Its Total Revenue

10.12.3 QIAGEN Tuberculosis Diagnostic Introduction

10.12.4 QIAGEN Revenue in Tuberculosis Diagnostic Business (2015-2020)

10.12.5 QIAGEN Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Disclaimer

15.3 Author Details

List of Tables

Table 1. Tuberculosis Diagnostic Key Market Segments

Table 2. Key Players Covered: Ranking by Tuberculosis Diagnostic Revenue

Table 3. Ranking of Global Top Tuberculosis Diagnostic Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Tuberculosis Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Radiographic Method

Table 6. Key Players of Diagnostic Laboratory Methods

Table 7. Key Players of Nucleic Acid Testing

Table 8. Key Players of Phage Assay

Table 9. Key Players of Detection of Latent Infection

Table 10. Key Players of Cytokine Detection Assay

Table 11. Key Players of Detection of Drug Resistance

Table 12. Global Tuberculosis Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 13. Global Tuberculosis Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026

Table 14. Global Tuberculosis Diagnostic Market Size by Regions (2015-2020) (US$ Million)

Table 15. Global Tuberculosis Diagnostic Market Share by Regions (2015-2020)

Table 16. Global Tuberculosis Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 17. Global Tuberculosis Diagnostic Market Share by Regions (2021-2026)

Table 18. Market Top Trends

Table 19. Key Drivers: Impact Analysis

Table 20. Key Challenges

Table 21. Tuberculosis Diagnostic Market Growth Strategy

Table 22. Main Points Interviewed from Key Tuberculosis Diagnostic Players

Table 23. Global Tuberculosis Diagnostic Revenue by Players (2015-2020) (Million US$)

Table 24. Global Tuberculosis Diagnostic Market Share by Players (2015-2020)

Table 25. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostic as of 2019)

Table 26. Global Tuberculosis Diagnostic by Players Market Concentration Ratio (CR5 and HHI)

Table 27. Key Players Headquarters and Area Served

Table 28. Key Players Tuberculosis Diagnostic Product Solution and Service

Table 29. Date of Enter into Tuberculosis Diagnostic Market

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Tuberculosis Diagnostic Market Size by Type (2015-2020) (Million US$)

Table 32. Global Tuberculosis Diagnostic Market Size Share by Type (2015-2020)

Table 33. Global Tuberculosis Diagnostic Revenue Market Share by Type (2021-2026)

Table 34. Global Tuberculosis Diagnostic Market Size Share by Application (2015-2020)

Table 35. Global Tuberculosis Diagnostic Market Size by Application (2015-2020) (Million US$)

Table 36. Global Tuberculosis Diagnostic Market Size Share by Application (2021-2026)

Table 37. North America Key Players Tuberculosis Diagnostic Revenue (2019-2020) (Million US$)

Table 38. North America Key Players Tuberculosis Diagnostic Market Share (2019-2020)

Table 39. North America Tuberculosis Diagnostic Market Size by Type (2015-2020) (Million US$)

Table 40. North America Tuberculosis Diagnostic Market Share by Type (2015-2020)

Table 41. North America Tuberculosis Diagnostic Market Size by Application (2015-2020) (Million US$)

Table 42. North America Tuberculosis Diagnostic Market Share by Application (2015-2020)

Table 43. Europe Key Players Tuberculosis Diagnostic Revenue (2019-2020) (Million US$)

Table 44. Europe Key Players Tuberculosis Diagnostic Market Share (2019-2020)

Table 45. Europe Tuberculosis Diagnostic Market Size by Type (2015-2020) (Million US$)

Table 46. Europe Tuberculosis Diagnostic Market Share by Type (2015-2020)

Table 47. Europe Tuberculosis Diagnostic Market Size by Application (2015-2020) (Million US$)

Table 48. Europe Tuberculosis Diagnostic Market Share by Application (2015-2020)

Table 49. China Key Players Tuberculosis Diagnostic Revenue (2019-2020) (Million US$)

Table 50. China Key Players Tuberculosis Diagnostic Market Share (2019-2020)

Table 51. China Tuberculosis Diagnostic Market Size by Type (2015-2020) (Million US$)

Table 52. China Tuberculosis Diagnostic Market Share by Type (2015-2020)

Table 53. China Tuberculosis Diagnostic Market Size by Application (2015-2020) (Million US$)

Table 54. China Tuberculosis Diagnostic Market Share by Application (2015-2020)

Table 55. Japan Key Players Tuberculosis Diagnostic Revenue (2019-2020) (Million US$)

Table 56. Japan Key Players Tuberculosis Diagnostic Market Share (2019-2020)

Table 57. Japan Tuberculosis Diagnostic Market Size by Type (2015-2020) (Million US$)

Table 58. Japan Tuberculosis Diagnostic Market Share by Type (2015-2020)

Table 59. Japan Tuberculosis Diagnostic Market Size by Application (2015-2020) (Million US$)

Table 60. Japan Tuberculosis Diagnostic Market Share by Application (2015-2020)

Table 61. Southeast Asia Key Players Tuberculosis Diagnostic Revenue (2019-2020) (Million US$)

Table 62. Southeast Asia Key Players Tuberculosis Diagnostic Market Share (2019-2020)

Table 63. Southeast Asia Tuberculosis Diagnostic Market Size by Type (2015-2020) (Million US$)

Table 64. Southeast Asia Tuberculosis Diagnostic Market Share by Type (2015-2020)

Table 65. Southeast Asia Tuberculosis Diagnostic Market Size by Application (2015-2020) (Million US$)

Table 66. Southeast Asia Tuberculosis Diagnostic Market Share by Application (2015-2020)

Table 67. India Key Players Tuberculosis Diagnostic Revenue (2019-2020) (Million US$)

Table 68. India Key Players Tuberculosis Diagnostic Market Share (2019-2020)

Table 69. India Tuberculosis Diagnostic Market Size by Type (2015-2020) (Million US$)

Table 70. India Tuberculosis Diagnostic Market Share by Type (2015-2020)

Table 71. India Tuberculosis Diagnostic Market Size by Application (2015-2020) (Million US$)

Table 72. India Tuberculosis Diagnostic Market Share by Application (2015-2020)

Table 73. Central & South America Key Players Tuberculosis Diagnostic Revenue (2019-2020) (Million US$)

Table 74. Central & South America Key Players Tuberculosis Diagnostic Market Share (2019-2020)

Table 75. Central & South America Tuberculosis Diagnostic Market Size by Type (2015-2020) (Million US$)

Table 76. Central & South America Tuberculosis Diagnostic Market Share by Type (2015-2020)

Table 77. Central & South America Tuberculosis Diagnostic Market Size by Application (2015-2020) (Million US$)

Table 78. Central & South America Tuberculosis Diagnostic Market Share by Application (2015-2020)

Table 79. Thermo Fisher Scientific Company Details

Table 80. Thermo Fisher Scientific Business Overview

Table 81. Thermo Fisher Scientific Product

Table 82. Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 83. Thermo Fisher Scientific Recent Development

Table 84. Hologic Corporation Company Details

Table 85. Hologic Corporation Business Overview

Table 86. Hologic Corporation Product

Table 87. Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 88. Hologic Corporation Recent Development

Table 89. Abbott Laboratories Company Details

Table 90. Abbott Laboratories Business Overview

Table 91. Abbott Laboratories Product

Table 92. Abbott Laboratories Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 93. Abbott Laboratories Recent Development

Table 94. Abbott Company Details

Table 95. Abbott Business Overview

Table 96. Abbott Product

Table 97. Abbott Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 98. Abbott Recent Development

Table 99. Becton Company Details

Table 100. Becton Business Overview

Table 101. Becton Product

Table 102. Becton Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 103. Becton Recent Development

Table 104. Dickinson and Company Company Details

Table 105. Dickinson and Company Business Overview

Table 106. Dickinson and Company Product

Table 107. Dickinson and Company Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 108. Dickinson and Company Recent Development

Table 109. F. Hoffmann-La Roche Company Details

Table 110. F. Hoffmann-La Roche Business Overview

Table 111. F. Hoffmann-La Roche Product

Table 112. F. Hoffmann-La Roche Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 113. F. Hoffmann-La Roche Recent Development

Table 114. bioMerieux Business Overview

Table 115. bioMerieux Product

Table 116. bioMerieux Company Details

Table 117. bioMerieux Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 118. bioMerieux Recent Development

Table 119. Sanofi Company Details

Table 120. Sanofi Business Overview

Table 121. Sanofi Product

Table 122. Sanofi Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 123. Sanofi Recent Development

Table 124. Cepheid Company Details

Table 125. Cepheid Business Overview

Table 126. Cepheid Product

Table 127. Cepheid Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 128. Cepheid Recent Development

Table 129. Hain Lifescience Company Details

Table 130. Hain Lifescience Business Overview

Table 131. Hain Lifescience Product

Table 132. Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 133. Hain Lifescience Recent Development

Table 134. QIAGEN Company Details

Table 135. QIAGEN Business Overview

Table 136. QIAGEN Product

Table 137. QIAGEN Revenue in Tuberculosis Diagnostic Business (2015-2020) (Million US$)

Table 138. QIAGEN Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tuberculosis Diagnostic Market Share by Type: 2020 VS 2026

Figure 2. Radiographic Method Features

Figure 3. Diagnostic Laboratory Methods Features

Figure 4. Nucleic Acid Testing Features

Figure 5. Phage Assay Features

Figure 6. Detection of Latent Infection Features

Figure 7. Cytokine Detection Assay Features

Figure 8. Detection of Drug Resistance Features

Figure 9. Global Tuberculosis Diagnostic Market Share by Application: 2020 VS 2026

Figure 10. Infants Case Studies

Figure 11. Adults Case Studies

Figure 12. Tuberculosis Diagnostic Report Years Considered

Figure 13. Global Tuberculosis Diagnostic Market Size YoY Growth 2015-2026 (US$ Million)

Figure 14. Global Tuberculosis Diagnostic Market Share by Regions: 2020 VS 2026

Figure 15. Global Tuberculosis Diagnostic Market Share by Regions (2021-2026)

Figure 16. Porter's Five Forces Analysis

Figure 17. Global Tuberculosis Diagnostic Market Share by Players in 2019

Figure 18. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostic as of 2019

Figure 19. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostic Revenue in 2019

Figure 20. North America Tuberculosis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. Europe Tuberculosis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. China Tuberculosis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Japan Tuberculosis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. Southeast Asia Tuberculosis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. India Tuberculosis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)

Figure 26. Central & South America Tuberculosis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)

Figure 27. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018

Figure 28. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 29. Hologic Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 30. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 31. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018

Figure 32. Abbott Laboratories Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 33. Abbott Total Revenue (US$ Million): 2019 Compared with 2018

Figure 34. Abbott Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 35. Becton Total Revenue (US$ Million): 2019 Compared with 2018

Figure 36. Becton Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 37. Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018

Figure 38. Dickinson and Company Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 39. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018

Figure 40. F. Hoffmann-La Roche Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 41. bioMerieux Total Revenue (US$ Million): 2019 Compared with 2018

Figure 42. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 43. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 44. Sanofi Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 45. Cepheid Total Revenue (US$ Million): 2019 Compared with 2018

Figure 46. Cepheid Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 47. Hain Lifescience Total Revenue (US$ Million): 2019 Compared with 2018

Figure 48. Hain Lifescience Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 49. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostic Business (2015-2020)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Tuberculosis Diagnostic Market Size, Status and Forecast 2020-2026

Published Date: 2020-03-11

Report Code: QYRE-Auto-12V1854

Global Tuberculosis Diagnostic Market Size, Status and Forecast 2020-2026

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions